Sociedad de Metabolismo y Corazón, S.C.

Veracruz C.P. 91900

2 studies enrolling now · 6 studies all time

What they study most

Atopic Dermatitis, Cardiovascular Diseases, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Gastroparesis, Hypertension, Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer, SARS-CoV-2 Infection, COVID-19, Unresectable Head and Neck Squamous Cell Carcinoma

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease — Running, not enrolling
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children — Completed
• JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis — Completed
• Diabetic Gastroparesis Study 05 — Stopped early